Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: A review

Current Diabetes Reviews

Volumn 8, Issue 4, 2012, Pages 274-284

  Luttrull, Jeffrey K ^a   Dorin, Giorgio ^b  

^a IRIDEX Corporation ^*  (United States)

^b IRIDEX Corporation   (United States)

Author keywords

Diabetes; Diabetic macular edema; Diabetic retinopathy; Diode laser; Invisible; Micropulse; Photocoagulation; Photostimulation; Phototherapy; Subthreshold

Indexed keywords

CYTOKINE; RANIBIZUMAB; VASCULOTROPIN;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CYTOKINE PRODUCTION; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE SEVERITY; DOSIMETRY; EPIDEMIOLOGICAL DATA; HISTOPATHOLOGY; HUMAN; INCIDENCE; LASER; LASER COAGULATION; LASER SURGERY; OPTICAL COHERENCE TOMOGRAPHY; PATIENT SAFETY; PHOTOTHERAPY; PIGMENT EPITHELIUM; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE; RETINA; RETINA DISEASE; RETINA INJURY; RETINA VASCULITIS; RISK BENEFIT ANALYSIS; RISK FACTOR; SUBTHRESHOLD DIODE MICROPULSE LASER PHOTOCOAGULATION; THERMAL RETINAL PHOTOCOAGULATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84862603978     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339912800840523     Document Type: Article

References (76)

1. Cover TM, Thomas JA. Elements of information theory. Copyright 1991 John Wiley & Sons, Inc. Print ISBN 0-471-06259-6 Online ISBN 0-471-20061-1.
2. Shah AM, Bressler NM, Jampol LM. Does laser still have a role in the management of retinal vascular and neovascular disease? Am J Ophthalmol 2011; 152: 332-9.
3. Laursen ML, Moeller F, Sander B, et al. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol 2004; 88: 1173-9.
4. Luttrull JK, Musch DC, Mainster MA. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol 2005; 89: 74-80.
5. Luttrull JK, Sramek C, Palanker D, Spink CJ, Musch DC. Longterm safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema. Retina 2012; 32: 375-86.
6. Luttrull JK, Spink CA. Serial optical coherence tomography of subthreshold diode micropulse photocoagulation for diabetic macular edema. Ophthalmic Surg Lasers Imaging 2006; 37: 370-377.
7. Lavinsky D, Cardillo JA, Melo LA Jr, Dare A, Farah ME, Belfort R Jr. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest Ophthalmol Vis Sci 2011; 52: 4314-23.
8. Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E. Microperimetry and fundus autofluorescence in diabetic macular edema. Subthreshold micropulse diode laser versus modified Early Treatment Diabetic Retinopathy Study Laser photocoagulation. Retina 2010; 30: 908-16.
9. Venkatesh P, Ramanjulu R, Azad R, Vohra R, Garg S. Subthreshold micropulse diode laser and double frequency neodymium: YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography. Photomed Laser Surg 2011; 29: 727-33.
10. Ohkoshi K, Yamaguchi T. Subthreshold micropulse diode laser photocoagulation for diabetic macular edema in Japanese patients. Am J Ophthalmol 2010; 149: 133-9.
11. DCCT Research Group. The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Med 1993; 329: 977-86.
12. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995; 102: 7-16.
13. Centers for Disease Control (www.cdc.gov/diabetes/news/docs/dpp.htm).
14. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS report no. 1. Arch Ophthalmol 1985; 103: 1796-806.
15. Wetzig P, Jepson C. Treatment of diabetic retinopathy by light coagulation: a preliminary study. Br J Ophthalmol 1963; 47: 539-41.
16. Beetham W, Aiello L, Balodimos M, et al. Ruby laser photocoagulation of early diabetic neovascular retinopathy: preliminary report of a long-term controlled study. Arch Ophthalmol 1970; 83: 261-72.
17. Schatz H, Madeira D, McDonald HR, et al. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 1991; 109: 1549-51.
18. Morgan CM, Schatz H. Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation. Ophthalmology 1989; 96: 96-103.
19. Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no 19. Arch Ophthalmol 1995; 113: 1144-55.
20. Lewen RM. Subretinal neovascularization complicating laser photocoagulation of diabetic maculopathy. Ophthalmic Surg 1988; 19: 734-7.
21. Lewis H, Schachat AP, Haimann MH, et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 1990; 97: 503-10, discussion 10-1.
22. Guyer DR, D'Amico DJ, Smith CW. Subretinal fibrosis after laser photocoagulation for diabetic macular edema. Am J Ophthalmol 1992; 113: 652-6.
23. Rutledge BK, Wallow IH, Poulsen GL. Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema. Arch Ophthalmol 1993; 111: 608-13.
24. Striph GG, Hart WM Jr, Olk RJ. Modified grid laser photocoagulation for diabetic macular edema. The effect on the central visual field. Ophthalmology 1988; 95: 1673-9.
25. Mainster MA. Decreasing retinal photocoagulation damage: principles and techniques. Sem Ophthalmol 1999; 14: 200-9.
26. Olk RJ. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1986; 93: 938-50.
27. Olk RJ. Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1990; 97: 1101-12, discussion 12-13.
28. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalmology 1991; 98: 1594-602.
29. Akduman L, Olk RJ. Diode laser (810 nm) versus argon green (514 nm) modified grid photocoagulation for diffuse diabetic macular edema. Ophthalmology 1997; 104: 1433-41.
30. Akduman L, Olk RJ. Subthreshold (subvisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME). Ophthalmic Surg Lasers 1999; 30: 706-14.
31. Roider J, Brinkmann R, Wirbelauer C, et al. Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. Br J Ophthalmol 2000; 84: 40-7.
32. Olk RJ, Akduman L. Minimal intensity diode laser (810 nanometer) photocoagulation (MIP) for diffuse diabetic macular edema (DDME). Sem Ophthalmol 2001; 16: 25-30.
33. Blumenkranz MS. Optimal current and future treatments for diabetic macular oedema. Eye 2010; 24: 428-34.
34. Pankratov MM. Pulsed delivery of laser energy in experimental thermal retinal photocoagulation. Proc Soc Photo-Optical Instrum Eng 1990; 1202: 205-13.
35. Dorin G. Subthreshold and micropulse photocoagulation. Sem Opthalmol 2003; 18: 147-53.
36. Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology 1997; 104: 2030-8.
37. Moorman CM, Hamilton AM. Clinical applications of the Micro- Pulse diode laser. Eye 1999; 13: 145-50.
38. Nakamura Y, Mitamura Y, Ogata K, et al. Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular oedema. Eye 2010; 24: 784-8.
39. Figueira J, Khan J, Nunes S, et al. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol 2009; 93: 1341-4.
40. Takatsuna Y, Yamamoto S, Nakamura Y. Long-term therapeutic efficacy of the subthreshold micropulse diode laser photocoagulation for diabetic macular edema. Jpn J Ophthalmol 2011; 55: 365-9.
41. Stanga PE, Reck AC, Hamilton AM. Micropulse laser in the treatment of diabetic macular edema. Semin Ophthalmol 1999; 14: 210-3.
42. Nagpal M, Marlecha S, Nagpal K. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina 2010; 30: 452-8.
43. Chappelow AV, Tan K, Waheed NK, et al. Panretinal photocoagulation for proliferative diabetic retinopathy: Pattern Scan Laser versus argon laser. Am J Ophthalmol 2012; 153: 137-42.
44. Luttrull JK. Subthreshold retinal photocoagulation for diabetic retinopathy. In: Boyd S, Cortez R, Sabates N, Eds. Retinal and Vitreoretinal Diseases and Surgery. Chapter 7. ISBN: 98-9962-678- 23-6. Jaypee- Highlighlights Medical Publishers, Inc, Panama, Rep. of Panama 2010. pp. 84-109.
45. Bhagat N, Zarbin M. Use of subthreshold diode micropulse laser for treating diabetic macular edema. Contemp Ophthalmol 2004; 3: 1-5.
46. Friberg TR. Subthreshold (invisible) modified grid diode laser photocoagulation and diffuse diabetic macular edema. Ophthalmic Surg Lasers 1999; 30: 705.
47. Lange CA, Stavrakas P, Luhmann UF, et al. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy. Am J Ophthalmol 2011; 152: 406-12.
48. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. RESTORE study group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011; 118: 615-25.
49. Gao X, Xing D. Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci 2009; 16: 4. Doci: 10.1186/1423-0127-16-4.
50. Duh EJ, Yang HS, Suzuma I, Miyagi M, et al. Pigment epitheliumderived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 2002; 43: 821-9.
51. Sohn HJ, Han DH, Kim IT, et al. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol 2011; 152: 686-94.
52. Masoud S, Heidari GK, Alireza R, et al. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Retina 2012; 32: 314-321.
53. Spinas GA, Mandrup-Poulsen T, Molvig J, et al. Low concentrations of interleukin-1 stimulate and high concentrations inhibit in sulin release from isolated rat islets of Langerhans. Acta Endocrinol (Copenhagen) 1986; 113: 551-558.
54. Luttrull JK, Spink CJ, Musch DA. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Eye 2008; 22: 607-612.
55. Flaxel C, Bradle J, Acott T, et al. Retinal pigment epithelium produces matrix metalloproteinases after laser treatment. Retina 2007; 27: 629-634.
56. Miura Y, Treumer F, Klettner A, et al. VEGF and PEDF secretions over time following various laser irradiations on an RPE organ culture. Invest Ophthalmol Vis Sci 2010; 51(5): 469.
57. Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF, Aiello LP, et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 2007 Apr; 125(4): 469-80.
58. Palanker D, Lavinsky D, Blumenkranz MS, Marcellino G. The impact of pulse duration and burn grade on size of retinal photocoagulation lesion: Implications for pattern density. Retina 2011; 31(8): 1664-9.
59. American National Standards Institute. American national standard for the safe use of lasers, ANSI Z136.1-2000. Washington, DC: American National Standards Institute, 2000.
60. Sliney DH, Wolbarsht ML. Safety with lasers and other optical sources: a comprehensive handbook. New York: Plenum Press, 1980: 1035.
61. Sliney DH, Mellerio J, Gabel VP, et al. What is the meaning of threshold in laser injury experiments? Implications for human exposure limits. Health Phys 2002; 82: 335-47.
62. Mainster MA, Turner PL. Retinal injuries from light: mechanisms, hazards and prevention. In: Ryan SJ, Ogden TE, Hinton DR, Schachat AP, Eds. Retina. London: Elsevier Publishers, 2004: 2.
63. Squirrell DM, Stewart AW, Joondeph BC, et al. Large-spot subthreshold infrared laser to treat diabetic macular edema. Retina 2008; 28 (4): 615-21.
64. Sramek C, Mackanos M, Spitler R, et al. Non-damaging retinal phototherapy: dynamic range of heat shock protein expression. Invest Ophthalmol Vis Sci. 2011; 52(3): 1780-7.
65. Strom C, Sander B, Larsen N, Larsen M, Lund-Andersen H. Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Invest Ophthalmol Vis Sci 2002; 43: 241-5.
66. Moreira RO, Trujillo FR, Meirelles RM, Ellinger VC, Zagury L. Use of optical coherence tomography (OCT) and indirect ophthalmoscopy in the diagnosis of macular edema in diabetic patients. Int Ophthalmol 2001; 24: 331-6.
67. Brown JC, Solomon SD, Bressler SB. Detection of diabetic foveal edema. Arch Ophthalmol. 2004; 122: 330-5.
68. Panozzo G, Gusson E, Parolini B, et al. Role of OCT in the diagnosis and follow up of diabetic macular edema. Semin Ophthalmol 2003; 18: 74-81.
69. Smiddy WE. Economic considerations of macular edema therapies. Ophthalmology 2011; 118(9): 1827-33.
70. Parodi MB, Spasse S, Iacono P, Di Stefano G, Canziani T, Ravalico G. Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology 2006; 113(12): 2237-42.
71. Parodi MB, Iacono P, Ravalico G. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular edema in branch retinal vein occlusion: A pilot study. Br J Ophthalmol 2008; 92(8): 1046-50.
72. Lanzetta P, Furlan F, Morgante L, Verritti D, Bandello F. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol 2008; 18(6): 934-40.
73. Koss MJ, Berger I, Koch FH. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye 2012; 26: 307-14.
74. Troutbeck R, Al-Qureshi S, Guymer RH. Therapeutic targeting of the complement system in age-related macular degeneration: a review. Clin Exp Ophthalmol 2012; 40(1): 18-26.
75. Sivaprasad S, Sandu R, Tandon A, et al. Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: A three-year follow up. Clin Exp Ophthalmol 2007; 35(7): 640-4.
76. Sivaprasad S, Elagouz M, McHugh D, Shona O, Dorin G. Micropulsed diode laser therapy: evolution and clinical applications. Surv Ophthalmol 2010; 55(6): 516-30.